255 related articles for article (PubMed ID: 16181131)
21. Positron emission tomography in oncology.
Berry JD; Cook GJ
Br Med Bull; 2006; 79-80():171-86. PubMed ID: 17169969
[TBL] [Abstract][Full Text] [Related]
22. Preclinical anatomical, molecular, and functional imaging of the lung with multiple modalities.
Gammon ST; Foje N; Brewer EM; Owers E; Downs CA; Budde MD; Leevy WM; Helms MN
Am J Physiol Lung Cell Mol Physiol; 2014 May; 306(10):L897-914. PubMed ID: 24658139
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography imaging using radiolabeled inorganic nanomaterials.
Sun X; Cai W; Chen X
Acc Chem Res; 2015 Feb; 48(2):286-94. PubMed ID: 25635467
[TBL] [Abstract][Full Text] [Related]
24. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development.
Lever JR
Curr Pharm Des; 2007; 13(1):33-49. PubMed ID: 17266587
[TBL] [Abstract][Full Text] [Related]
25. PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET.
Slobbe P; Poot AJ; Windhorst AD; van Dongen GA
Drug Discov Today; 2012 Nov; 17(21-22):1175-87. PubMed ID: 22766374
[TBL] [Abstract][Full Text] [Related]
26. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
[TBL] [Abstract][Full Text] [Related]
27. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
28. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
29. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [
Eberl S; Katsifis A; Peyronneau MA; Wen L; Henderson D; Loc'h C; Greguric I; Verschuer J; Pham T; Lam P; Mattner F; Mohamed A; Fulham MJ
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):296-307. PubMed ID: 27699720
[TBL] [Abstract][Full Text] [Related]
30. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers.
Cerqueira M; Case J; Maddahi J
J Nucl Cardiol; 2015 Aug; 22(4):730-9. PubMed ID: 26129941
[No Abstract] [Full Text] [Related]
31. Molecular tracers for the PET and SPECT imaging of disease.
Pimlott SL; Sutherland A
Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
[TBL] [Abstract][Full Text] [Related]
32. RGD-based PET tracers for imaging receptor integrin αv β3 expression.
Cai H; Conti PS
J Labelled Comp Radiopharm; 2013 May; 56(5):264-79. PubMed ID: 24285371
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
Ruangma A; Bai B; Lewis JS; Sun X; Welch MJ; Leahy R; Laforest R
Nucl Med Biol; 2006 Feb; 33(2):217-26. PubMed ID: 16546676
[TBL] [Abstract][Full Text] [Related]
34. Immuno-PET: a navigator in monoclonal antibody development and applications.
van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
[TBL] [Abstract][Full Text] [Related]
35. Cardiac positron emission tomography imaging.
Machac J
Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
[TBL] [Abstract][Full Text] [Related]
36. Small molecule PET-radiopharmaceuticals.
Elsinga PH; Dierckx RA
Curr Pharm Des; 2014; 20(14):2268-74. PubMed ID: 24025105
[TBL] [Abstract][Full Text] [Related]
37. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
Olivas Arroyo C
Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
[TBL] [Abstract][Full Text] [Related]
38. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
[TBL] [Abstract][Full Text] [Related]
39. Developing new molecular imaging probes for PET.
Serdons K; Verbruggen A; Bormans GM
Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
